McKesson (MCK) vs Nu Skin Enterprises (NUS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
McKesson (MCK) has outperformed Nu Skin Enterprises (NUS) over the past year, gaining 21.4% versus a loss of 56.8%. Over five years, MCK leads with a +345.9% price change compared with -88.3% for NUS. McKesson is the larger company by market cap ($106.14 billion vs $233.6 million), about 454.3 times the size.
On valuation, Nu Skin Enterprises trades at a lower forward P/E (4.1x vs 18.0x for McKesson). Nu Skin Enterprises offers the higher dividend yield (5.00% vs 0.36%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MCK | NUS |
|---|---|---|
| Share price | $910.33 | $4.80 |
| Market cap | $106.14B | $233.65M |
| 1-day change | -1.23% | +1.27% |
| YTD return | +10.98% | -50.10% |
| 1-year return | +21.36% | -56.80% |
| 5-year return | +345.87% | -88.30% |
| P/E ratio (TTM) | 24.24 | — |
| Forward P/E | 18.04 | 4.14 |
| EPS (TTM) | $37.56 | $-4.51 |
| Dividend yield | 0.36% | 5.00% |
| Annual dividend | $3.28 | $0.24 |
| Revenue (latest FY) | $403.43B | — |
| Revenue growth (YoY) | +12.36% | — |
| Net income (latest FY) | $4.76B | — |
| Gross margin | 3.61% | — |
| Operating margin | 1.54% | — |
| Net margin | 1.18% | — |
| 52-week high | $999.00 | $11.67 |
| 52-week low | $723.68 | $4.45 |
| Distance from 52-week high | -8.88% | -58.87% |
| Analyst consensus | buy | none |
| Avg. price target upside | +7.36% | +166.04% |
| Average volume | 924.58K | 556.99K |
| Shares outstanding | 116.59M | 48.68M |
| Employees | 41,600 | 2,800 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- McKesson is about 454.3 times larger than Nu Skin Enterprises by market value ($106.14B vs $233.65M).
- MCK has outperformed NUS by 78.2 percentage points over the past year.
- Nu Skin Enterprises offers a meaningfully higher dividend yield (5.00% vs 0.36%).
About McKesson
MCK stock →McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Health Care · Other Pharmaceuticals · 41,600 employees
About Nu Skin Enterprises
NUS stock →Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands.
Health Care · Other Pharmaceuticals · 2,800 employees
MCK vs NUS FAQ
Which is bigger, McKesson or Nu Skin Enterprises?
McKesson (MCK) is larger, with a market capitalization of $106.14B compared with $233.65M for Nu Skin Enterprises (NUS).
Which stock has performed better over the past year, MCK or NUS?
MCK returned +21.36% over the past 12 months, compared with -56.80% for NUS (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, McKesson or Nu Skin Enterprises?
Nu Skin Enterprises has the higher yield at 5.00%, compared with 0.36% for McKesson.
Are McKesson and Nu Skin Enterprises in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.